<SEC-DOCUMENT>0001995218-25-000007-index.html : 20251120
<SEC-HEADER>0001995218-25-000007.hdr.sgml : 20251120
<ACCEPTANCE-DATETIME>20251120172129
ACCESSION NUMBER:		0001995218-25-000007
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251118
FILED AS OF DATE:		20251120
DATE AS OF CHANGE:		20251120

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Townsend Richard Nolan
		CENTRAL INDEX KEY:			0001995218
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41855
		FILM NUMBER:		251503967

	MAIL ADDRESS:	
		STREET 1:		C/O LEXEO THERAPEUTICS, INC.
		STREET 2:		345 PARK AVENUE SOUTH, 6TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexeo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001907108
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				854012572
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 547-9879

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-11202025_101125.xml
<TEXT>
Document 1 - file: form4-11202025_101125.html

Document 1 - RAW XML: form4-11202025_101125.xml

</DOCUMENT>
</SEC-DOCUMENT>